EUR/USD Price Forecast: Rallies fail above 1.1200 amid high Oil prices, debt woes
The Euro (EUR) is failing to capitalise on the moderate US Dollar (USD) weakness witnessed on Friday as the high Oil prices and the ongoing concerns about France’s public debt offset investors’ optimism about lower global yields. The EUR/USD pair treads water above 1.1200 ahead of the US session opening, halfway through the weekly trading range.
The US Dollar Index retreated on Thursday as a successful auction of US 30-year bonds eased concerns about government debt and sent long-term yields lower from multi-decade highs. The Euro, however, faces weaknesses of its own, as Brent prices remain above $100, threatening to tip Eurozone economies into stagflation, with French debt at historic highs and social unrest spreading across the country.
Earlier on Friday, St. Louis Fed President Alberto Musalem provided some support to the US Dollar, affirming that “more monetary policy will be needed” to bring inflation to the 2% target. Later on the day, the US Michigan Consumer Sentiment Index report might have some impact on US Dollar crosses, although the main focus remains on next week’s US Consumer Price Index (CPI) and Producer Price Index (PPI) figures, which might help to determine the timing of the Fed's next move.
Technical Indicators: Bearish momentum fades, but bulls do not show up
EUR/USD trades at 1.1214, keeping a bearish tone, on track to complete a 3.5% sell-off in a five-week losing streak. The 4-hour Relative Strength Index (14) remains capped below the 50 midline, while Moving Average Convergence Divergence (MACD) is marginally positive. These readings hint at stabilizing pressure, with bullish pressure still too weak to contemplate a bullish shift.
Price action is hovering halfway through the weekly horizontal channel, with immediate resistance at the October 2 and 8 highs around 1.1275. Further up, the next target emerges in the area between the late June lows at 1.1337 and the 38.2% Fibonacci retracement of the September-October downtrend, near 1.1350.
On the downside, immediate support emerges at the October 2 low, near 1.1160. Below here, the late May 2025 lows in the 1.1050 area emerge as a plausible target before the psychological 1.1000 level.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Leerink says concerns over growth in the medical technology sector may overshadow third-quarter performance
October 9 – Leerink Partners stated that, ahead of the third-quarter earnings reports, it remains cautious on the medical technology sector and pointed out that the short-term market environment is “somewhat uncertain.” The firm noted increasing competition in some markets, including the cardiac devices and diabetes care sectors; uncertainty in surgical volumes amid rising costs; weak consumer confidence; and pressure on hospital budgets due to higher interest rates. “We believe that even if third-quarter results are positive, they may be overshadowed by ongoing market concerns about profitability and growth prospects for 2027 and beyond,” the broker said. The firm believes that positive factors for specific companies could help Medtronic (MDT.N) and Tandem Diabetes Care (TNDM.O) outperform the broader industry during these sector-wide headwinds. The broker said it remains most cautious on PROCEPT BioRobotics (PRCT.O) and Insulet (PODD.O), as a slowdown in adoption and intensifying competition may lead to lowered expectations for 2027. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translation may contain errors or fail to capture the required context, Reuters does not guarantee the accuracy of automated translation texts, and they are provided merely for readers’ convenience. Reuters accepts no liability for any damage or loss resulting from the use of automated translation features.)
The strongest growth outlook in over two years is approaching! US medical device stocks still need to endure another sluggish earnings season
The third-quarter profit growth of medical device companies is expected to be only 4.8%, but it is projected to accelerate to 13% in the first quarter of next year, marking the strongest performance in over two years. However, policy uncertainties and product recalls have dampened confidence, and the market is awaiting a recovery by 2027.
BUZZ—US Stock Market Dynamics: SpaceX, Humana, Delta Air Lines
Workspace search string for querying individual stock trends: STXBZ "Today's Outlook" newsletter: https://refini.tv/3LI4BU7 "Morning News Brief": https://refini.tv/3dKUyB8 Reuters, October 9 — On Friday, U.S. stock index futures rose as oil prices retreated due to easing concerns over Middle East supply. However, telecom stocks remained under pressure as SpaceX's acquisition of spectrum sparked competition concerns across the telecom sector. - **T-Mobile US Inc (TMUS.O):** Hot topic — European telecom stocks fell after the SpaceX spectrum deal. [nL6N45V0EH] - **Space Exploration Technologies Corp (SPCX.O):** Hot topic — Shares rose after reaching an agreement to acquire a nationwide low-band spectrum portfolio. [nL4N45V0KP] - **Humana Inc (HUM.N):** Hot topic — Shares rose after its “Medicare Advantage” rating was raised. [nL4N45V0LU] - **Definium Therapeutics Inc (DFTX.O):** Market buzz — Shares increased after JPMorgan gave its LSD-based therapy an “Overweight” rating. [nL4N45V0NH] - **UnitedHealth Group Inc (UNH.N):** Market movement — TD Cowen lowered its target price ahead of UnitedHealth’s Q3 financial report. [nL4N45V0OU] - **Newmont Corporation (NEM.N):** - **Gold Fields Ltd (GFI.N):** - **Harmony Gold Mining Company Limited (HMY.N):** - **AngloGold Ashanti Ltd (AU.N):** Market movement — Gold miners’ shares rose in line with a slight rise in gold prices driven by a weaker dollar. [nL4N45V0PG] - **Delta Air Lines Inc (DAL.N):** Market flash — Shares fell after sharply lowering full-year profit forecast. [nL4N45V0RA] - **Apple Inc (AAPL.O):** Hot topic — Shares declined amid reports of iPhone production cuts. [nL4N45V0SB] - **Crescent Energy Company (CRGY.N):** Hot topic — Shares fell after raising 1 billion USD to acquire Devon Energy. [nL6N45V0J4] (For the convenience of non-English speakers, Reuters has automatically translated its reports into several other languages. As automated translations may contain errors or may not capture the necessary context, Reuters does not guarantee the accuracy of the automated translation text, which is provided solely for readers’ convenience. Reuters accepts no liability for any damage or loss caused by the use of this function.)
BlackRock trims TAG Immobilien voting rights to 6.68% from 6.81%
BlackRock cut its total TAG voting rights to 6.68% from 6.81% on Oct. 6, 2026. Equity stake rose to 5.15% from 4.71%. Positions via instruments fell to 1.54% from 2.10%. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TAG Immobilien AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2413388_en) on October 09, 2026, and is solely responsible for the information contained therein.
Crypto prices
More
